Quoin Pharmaceuticals Ltd. American Depositary Shares (QNRX)

About QNRX

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

4

Website

quoinpharma.com/

Fundamentals

1-day range

$5.95$8.25

Market cap

$9.18M

P/E (trailing)

—

P/E (forward)

-1.92

EPS (trailing)

$-16.49

Dividend yield

—

Beta

1.55

Avg. volume

237.7K

Dividend pay date

October 23, 2019

Forecasts

5 analyst ratings

Quoin Pharmaceuticals Ltd. American Depositary Shares Competitors

Chosen by industry and closest market cap.

• QNRX

  Quoin Pharmaceuticals Ltd. American Depositary Shares

  $6.13

  ▲ 18.91%
  Market cap $9.18MP/E —
  $3.25$41.8
• GDTC

  CytoMed Therapeutics Limited Ordinary Shares

  $0.92

  ▼ 4.17%
  Market cap $9.50MP/E —
  $0.6801$3.68
• LEXX

  Lexaria Bioscience Corp. Common Stock

  $10.35

  ▼ 11.39%
  Market cap $8.82MP/E —
  $4.21$23.25
• LSTA

  Lisata Therapeutics Inc. Common Stock

  $1.73

  ▼ 4.95%
  Market cap $9.74MP/E —
• XCUR

  Exicure Inc. Common Stock

  $1.34

  ▼ 5.32%
  Market cap $8.60MP/E —
• SNGX

  Soligenix Inc. Common Stock

  $0.38

  ▲ 0.00%
  Market cap $8.24MP/E —
  $0.28$3.22
• ADIL

  Adial Pharmaceuticals Inc Common Stock

  $5.6

  ▼ 1.41%
  Market cap $10.29MP/E —
  $1.31$249.81

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Quoin Pharmaceuticals Stock Surges Friday: What's Happening?
  benzinga · 8/28/2026
• 12 Health Care Stocks Moving In Friday's Intraday Session
  Benzinga · 8/14/2026
• Quoin Pharmaceuticals Q2 EPS $(1.90) Misses $(1.61) Estimate
  Benzinga · 8/14/2026

Institutional Ownership

March 31, 2026

Total shares held

1.18M

Total value held

$7.82M

Institutional holders

21